Gender effect on neurodegeneration and myelin markers in an animal model for multiple sclerosis

BMC Neurosci. 2012 Jan 24;13:12. doi: 10.1186/1471-2202-13-12.


Background: Multiple sclerosis (MS) varies considerably in its incidence and progression in females and males. In spite of clinical evidence, relatively few studies have explored molecular mechanisms possibly involved in gender-related differences. The present study describes possible cellular- and molecular-involved markers which are differentially regulated in male and female rats and result in gender-dependent EAE evolution and progression. Attention was focused on markers of myelination (MBP and PDGFαR) and neuronal distress and/or damage (GABA synthesis enzymes, GAD65 and GAD67, NGF, BDNF and related receptors), in two CNS areas, i.e. spinal cord and cerebellum, which are respectively severely and mildly affected by inflammation and demyelination. Tissues were sampled during acute, relapse/remission and chronic phases and results were analysed by two-way ANOVA.

Results: 1. A strong gender-dependent difference in myelin (MBP) and myelin precursor (PDGFαR) marker mRNA expression levels is observed in control animals in the spinal cord, but not in the cerebellum. This is the only gender-dependent difference in the expression level of the indicated markers in healthy animals; 2. both PDGFαR and MBP mRNAs in the spinal cord and MBP in the cerebellum are down-regulated during EAE in gender-dependent manner; 3. in the cerebellum, the expression profile of neuron-associated markers (GAD65, GAD67) is characterized by a substantial down-regulation during the inflammatory phase of the disease, which does not differ between male and female rats (two-way ANOVA); 4. there is an up-regulation of NGF, trkA and p75 mRNA expression in the early phases of the disease (14 and 21 days post-immunization), which is not different between male and female.

Conclusions: It is reported herein that the regulation of markers involved in demyelination and neuroprotection processes occurring during EAE, a well-established MS animal model, is gender- and time-dependent. These findings might contribute to gender- and phase disease-based therapy strategies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Cerebellum / metabolism
  • Cerebellum / pathology
  • Disease Models, Animal
  • Female
  • Freund's Adjuvant / adverse effects
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / physiology
  • Glutamate Decarboxylase / genetics
  • Glutamate Decarboxylase / metabolism
  • Male
  • Multiple Sclerosis / chemically induced
  • Multiple Sclerosis / complications
  • Multiple Sclerosis / metabolism*
  • Multiple Sclerosis / pathology
  • Myelin Basic Protein / genetics
  • Myelin Basic Protein / metabolism*
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism
  • Neurodegenerative Diseases / etiology
  • Neurodegenerative Diseases / metabolism*
  • Polysaccharides / genetics
  • Polysaccharides / metabolism
  • RNA, Messenger / metabolism
  • Rats
  • Receptor, Platelet-Derived Growth Factor alpha / genetics
  • Receptor, Platelet-Derived Growth Factor alpha / metabolism*
  • Sex Characteristics*
  • Spinal Cord / metabolism
  • Spinal Cord / pathology


  • Myelin Basic Protein
  • Nerve Tissue Proteins
  • Polysaccharides
  • RNA, Messenger
  • neurotropin
  • Freund's Adjuvant
  • Receptor, Platelet-Derived Growth Factor alpha
  • Glutamate Decarboxylase